Share on Facebook Share on Twitter Email
Answers.com

Raynaud's phenomenon

 
Dental Dictionary: Raynaud’s phenomenon

n

Spasm of the digital arteries with blanching and numbness of the extremities, induced by chilling, emotional states, or other diseases.

Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
Sports Science and Medicine: Raynaud's phenomenon
Top

A condition of unknown cause in which the arteries of the fingers become hyperreactive to the cold and go into a spasm. It is more common in women than men, and may affect up to 10% of otherwise healthy female athletes causing them great difficulties in cold environments. Warm gloves and calcium-channel blocking agents may relieve the condition.

Medical Dictionary: Raynaud's phenomenon
Top

n.

Sensitivity of the hands to cold due to spasms of the digital arteries, resulting in blanching and numbness of the fingers.

Wikipedia: Raynaud's phenomenon
Top
Raynaud's phenomenon
Classification and external resources

Hands with Raynaud's phenomenon
ICD-10 I73.0
ICD-9 443.0
DiseasesDB 25933
eMedicine med/1993
MeSH D011928

In medicine, Raynaud's phenomenon (pronounced /reɪˈnoʊz/, us dict: rā·nōz′) is a vasospastic disorder causing discoloration of the fingers, toes, and occasionally other extremities. This condition can also cause nails to become brittle with longitudinal ridges. Named for French physician Maurice Raynaud (1834–1881), the cause of the phenomenon is believed to be the result of vasospasms that decrease blood supply to the respective regions. Emotional stress and cold are classic triggers of the phenomenon, and the discoloration follows a characteristic pattern in time: white, blue and red.

It comprises both Raynaud's disease (primary Raynaud's), where the phenomenon is idiopathic,[1] and Raynaud's syndrome (secondary Raynaud's), where it is caused by some other instigating factor. Measurement of hand-temperature gradients is one tool used to distinguish between the primary and secondary forms.[2]

It is possible for the primary form to progress to the secondary form.[3]

Contents

Prevalence

The phenomenon is more common in women than men, with the Framingham Study finding that 5% of men and 8% of women suffer from it.[verification needed]

Epidemiology

There is a familial component to primary Raynaud's, and presentation is typically before two. Smoking worsens frequency and intensity of attacks, and there is a hormonal component. Caffeine also worsens the attacks. Sufferers are more likely to have migraine and angina than controls.

Secondary Raynaud's has a number of associations:

It is important to realise that Raynaud's can herald these diseases by periods of more than 20 years in some cases, making it effectively their first presenting symptom. This can be the case in the CREST syndrome, of which Raynaud's is a part.

Symptoms

The condition causes painful, pale, cold extremities. This can often be distressing to those who are not diagnosed, and sometimes it can be obstructive. If someone with Raynaud's is placed in too cold a climate, it could potentially become dangerous.

Unilateral Raynaud's, or that which is present only in the hands or feet, is almost certainly primary, and will probably not progress to a secondary condition. In pregnancy, this sign normally disappears due to increased surface blood flow. Raynaud's has also occurred in breastfeeding mothers, causing nipples to turn white and become extremely painful.[5] Nifedipine, a calcium channel blocker and vasodilator was recommended to increase blood flow to the extremities and noticeably relieved pain to the breast, in an extremely small study group.[6]

Examination

A careful history will often reveal whether the condition is primary or secondary. Once this has been established, an examination is largely to identify or exclude possible secondary causes.

Pathophysiology

Primary Raynaud phenomenon, stemming from Raynaud disease, is an exaggeration of vasomotor responses to cold or emotional stress. More specifically, it is a hyperactivation of the sympathetic system causing extreme vasoconstriction of the peripheral blood vessels, leading to tissue hypoxia. Chronic, recurrent cases of Raynaud phenomenon can result in atrophy of the skin, subcutaneous tissues, and muscle. It can also rarely cause ulceration and ischemic gangrene.[7] Erythromelalgia is the opposite of Raynaud's where the ends turn red hot from heat rather than cold.[8]

Treatment

Treatment options are dependent on the type of Raynaud's present. Raynaud's syndrome is treated primarily by addressing the underlying cause, but includes all options for Raynaud's disease as well. Treatment of primary Raynaud's focuses on avoiding triggers:

General Care

  • Avoid environmental triggers, e.g. cold, vibration, etc. Emotional stress is another recognized trigger; although the various sources of stress can not all be avoided, it is possible to learn healthier, more effective ways of dealing with them, which will reduce stress and its somatic pathology (damaging physical effects) overall.
  • Keep your hands, feet and head warm—especially your fingers, toes, ears and nose—by wearing mittens, insulated footwear, a ski mask; by using hand- and foot warmers (such as HeatBands), etc.
  • Quit smoking.
  • Avoid caffeine and other stimulants and vasoconstrictors that have not been prescribed to you by your doctor. Read product labels; caffeine is found not only in coffee and tea, stay-awake pills, many soft drinks and candies, but also in some cosmetics, soaps and shampoos, and even the fabric of undergarments.
  • Make sure all your doctors know about all the medicines you take and about all the OTC remedies you use, especially hormones and drugs that regulate hormones, such as hormonal contraception, so that these professionals can make an assessment of your chemical regimen and make any changes that may be indicated. Contraception which is low in estrogen is preferable, and the progesterone only pill is often prescribed for women with Raynaud's.
  • If you are diabetic, follow your diabetes treatment plan.

Emergency Measures

  • If white finger (Raynaud's) occurs unexpectedly and a source of warm water is available, allow tepid to slightly warm water to run over the affected digits while you gently massage the area. Continue this process until the white area returns to its normal, healthy color.
  • If triggered by exposure in a cold environment, and no warm water is available, place the affected digits in a warm body cavity - arm pit, crotch, or even in the mouth. Keep the affected area warm at least until the whiteness returns to its normal, healthy color. Get out of the cold as soon as possible.

Drug Therapy

  • Drug treatment is normally with a calcium channel blocker, frequently nifedipine to prevent arterioconstriction.[9][10] It has the usual common side effects of headache, flushing, and ankle edema; but these are not typically of sufficient severity to require cessation of treatment.[11]
  • There is some evidence that Angiotensin II receptor antagonists (often Losartan) reduce frequency and severity of attacks,[12] and possibly better than nifedipine.[13]
  • Alpha-1 adrenergic blockers such as prazosin can be used to control Raynaud's vasospasms under supervision of a health care provider.[14]
  • In a study published in the November 8, 2005 issue of Circulation, sildenafil (Viagra) improved both microcirculation and symptoms in patients with secondary Raynaud's phenomenon resistant to vasodilatory therapy. The authors, led by Dr Roland Fries (Gotthard-Schettler-Klinik, Bad Schönborn, Germany), report: "In the present study, capillary blood flow was severely impaired and sometimes hardly detectable in patients with Raynaud's phenomenon. Sildenafil led to a more than 400% increase of flow velocity."[15]

Surgical Intervention

Alternative and Experimental (Research) Approaches

  • The extract of the Ginkgo biloba leaves (Egb 761, 80 mg) may reduce frequency of attacks.[17]
  • Two separate gels combined on the fingertip (somewhat like two-part epoxy, they cannot be combined before use because they will react) increased blood flow in the fingertips by about three times. One gel contained 5% sodium nitrite and the other contained 5% ascorbic acid. The milliliter of combined gel covered an area of ~3 cm². The gel was wiped off after a few seconds.[18]
  • Piracetam

See also

References

  1. ^ Raynaud disease at Dorland's Medical Dictionary
  2. ^ Anderson ME, Moore TL, Lunt M, Herrick AL (2007). "The 'distal-dorsal difference': a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon". Rheumatology (Oxford) 46 (3): 533–8. doi:10.1093/rheumatology/kel330. PMID 17018538. http://rheumatology.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=17018538. 
  3. ^ Hirschl M, Hirschl K, Lenz M, Katzenschlager R, Hutter HP, Kundi M (2006). "Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance". Arthritis Rheum. 54 (6): 1974–81. doi:10.1002/art.21912. PMID 16732585. 
  4. ^ Gayraud M (2007). "Raynaud's phenomenon". Joint Bone Spine 74 (1): e1–8. doi:10.1016/j.jbspin.2006.07.002. PMID 17218139. http://linkinghub.elsevier.com/retrieve/pii/S1297-319X(06)00246-6. 
  5. ^ Holmen OL, Backe B (2009). "An underdiagnosed cause of nipple pain presented on a camera phone". BMJ 339: b2553. doi:10.1136/bmj.b2553. 
  6. ^ Anderson JE, Held N, Wright K (2004). "Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.". Pediatrics 113 (4): 360–364. doi:10.1542/peds.113.4.e360. PMID 15060268. 
  7. ^ Kumar, Vinay; Nelso Fausto, Abul Abbas (2004). Robbins & Cotran Pathologic Basis of Desease. Saunders. pp. 542. ISBN 0721601871. 
  8. ^ Berlin, Al, Pehr K (2004). "Coexistence of erythromelalgia and Raynaud's phenomenon.". J Am Acad Dermatol 50 (3): 456–60. doi:10.1016/S0190-9622(03)02121-2. PMID 14988692. 
  9. ^ Kahan A, Weber S, Amor B, Saporta L, Hodara M, Degeorges M (1981). "Nifedipine and Raynaud's phenomenon". Ann. Intern. Med. 94 (4 pt 1): 546. PMID 7212523. 
  10. ^ Kahan A, Weber S, Amor B, Saporta L, Hodara M, Degeorges M (1982). "[Controlled study of nifedipine in the treatment of Raynaud's phenomenon]" (in French). Rev Rhum Mal Osteoartic 49 (5): 337–43. PMID 6285445. 
  11. ^ Smith CR, Rodeheffer RJ (1985). "Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers". Am. J. Cardiol. 55 (3): 154B–157B. doi:10.1016/0002-9149(85)90625-3. PMID 3881908. 
  12. ^ Pancera P, Sansone S, Secchi S, Covi G, Lechi A (1997). "The effects of thromboxane A2 inhibition (picotamide) and angiotensin II receptor blockade (losartan) in primary Raynaud's phenomenon". J. Intern. Med. 242 (5): 373–6. doi:10.1046/j.1365-2796.1997.00219.x. PMID 9408065. 
  13. ^ Dziadzio M, Denton CP, Smith R, et al. (1999). "Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial" (PDF). Arthritis Rheum. 42 (12): 2646–55. doi:10.1002/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T. PMID 10616013. http://www3.interscience.wiley.com/cgi-bin/fulltext/78503570/PDFSTART. 
  14. ^ Waldo R (1979). "Prazosin relieves Raynaud's vasospasm". JAMA 241 (10): 1037. doi:10.1001/jama.241.10.1037. PMID 762741. 
  15. ^ Fries R, Shariat K, von Wilmowsky H, Böhm M (2005). "Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy". Circulation 112 (19): 2980–5. doi:10.1161/CIRCULATIONAHA.104.523324 (inactive 2008-06-21). PMID 16275885. http://circ.ahajournals.org/cgi/content/full/112/19/2980. 
  16. ^ Wang WH, Lai CS, Chang KP, et al. (2006). "Peripheral sympathectomy for Raynaud's phenomenon: a salvage procedure". Kaohsiung J. Med. Sci. 22 (10): 491–9. doi:10.1016/S1607-551X(09)70343-2. PMID 17098681. http://health.elsevier.com/ajws_pubmed/pubmed_switch.asp?journal_issn=1607-551X&art_pub_year=2006&%20art_pub_month=10&art_pub_vol=22&art_sp=491. 
  17. ^ Muir AH, Robb R, McLaren M, Daly F, Belch JJ (2002). "The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial". Vasc Med 7 (4): 265–7. doi:10.1191/1358863x02vm455oa. PMID 12710841. 
  18. ^ Tucker AT, Pearson RM, Cooke ED, Benjamin N (Nov 13 1999). "Effect of nitric-oxide-generating system on microcirculatory blood flow in skin of patients with severe Raynaud's syndrome: a randomised trial". Lancet 354 (9191): 1670–5. doi:10.1016/S0140-6736(99)04095-7. PMID 10568568. 

External links

Template:Vascular Diseases


 
 

 

Copyrights:

Dental Dictionary. Mosby's Dental Dictionary. Copyright © 2004 by Elsevier, Inc. All rights reserved.  Read more
Sports Science and Medicine. The Oxford Dictionary of Sports Science & Medicine. Copyright © Michael Kent 1998, 2006, 2007. All rights reserved.  Read more
Medical Dictionary. The American Heritage® Stedman's Medical Dictionary Copyright © 2002, 2001, 1995 by Houghton Mifflin Company Read more
Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Raynaud's phenomenon" Read more